NEW YORK, NY / ACCESSWIRE / October 6, 2017 / Financials and information technology stocks lifted the S&P 500 Index to its sixth consecutive record close and its first 8-day win streak since 2013. The S&P 500 Index rose 0.56 percent to close at a record 22,775.39, up approximately 14.0 percent year-to-date. The Dow Jones Industrial Average increased 0.50 percent to close at 2,552.07, up approximately 15.25 percent year-to-date, while the tech-heavy Nasdaq Composite Index jumped 0.78 percent to close at 6,585.36, up approximately 22.33 percent year-to-date.

"Investors are looking at broad economic growth, and not just in the U.S., but globally," said Kate Warne, investment strategist at Edward Jones. "Investors are also looking ahead to earnings season and are feeling optimistic about companies."

RDI Initiates Coverage on:

Ionis Pharmaceuticals Inc.
https://rdinvesting.com/news/?ticker=IONS

HTG Molecular Diagnostics Inc.
https://rdinvesting.com/news/?ticker=HTGM

Ionis Pharmaceuticals Inc.'s stock moved 3.13% higher Thursday, to close the day at $56.01. The stock recorded a trading volume of 1,006,270 shares, which was below its three months average volume of 1,244,530 shares. In the last year, Ionis Pharmaceuticals Inc.'s shares have traded in a range of 24.58 - 60.01. The share price has gained 127.87% from its 52-week low. The company's shares are currently trading above their 200-day moving average. Moreover, the stock's 50-day moving average of $52.79 is greater than its 200-day moving average of $48.81. Shares of the company are trading at a Price to Earnings ratio of 269.28. Shares of Ionis Pharmaceuticals have gained approximately 17.1 percent year-to-date.

Access RDI's Ionis Pharmaceuticals Inc. Research Report at:
https://rdinvesting.com/news/?ticker=IONS

On Thursday, shares in HTG Molecular Diagnostics Inc. recorded a trading volume of 4,246,370 shares, which was above the three months average volume of 763,675 shares. The stock ended the day 14.44% higher at 2.06. The share price has gained 71.67% from its 52-week low with a 52-week trading range of 1.20 - 4.45.The company's shares are currently trading above their 200-day moving average. Moreover, the stock's 50-day moving average of $1.84 is at its 200-day moving average of $1.84. Shares of HTG Molecular Diagnostics have fallen approximately 8.04 percent year-to-date.

Access RDI's HTG Molecular Diagnostics Inc. Research Report at:
https://rdinvesting.com/news/?ticker=HTGM

Our Actionable Research on Ionis Pharmaceuticals Inc. (NASDAQ:IONS) and HTG Molecular Diagnostics Inc. (NASDAQ:HTGM) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com